Tag Archives: Sirturo

TB drug approvals, distribution deal inches options forward, but MDR TB treatment access still uncertain where needed most

By on .

Last week’s developments in TB treatment included the announcement that bedaquiline, the currently most promising medicine for multi-drug-resistant tuberculosis, will become available to patients in 130 low- and middle-income countries through the Stop TB Partnership’s Global Drug Facility. That good news for multidrug-resistant TB patients, many of whom have run out of other options, was […]

Wrapping up CROI 2013, Part I: TB on the verge, VOICE trial point to future research needs, sequestration consequence points to rough road ahead

By on .

Science Speaks spent March 3 – 6 at the Conference on Retroviruses and Opportunistic Infections, covering breaking research news and discussions. Today and tomorrow we will wrap up with summaries of sessions, and questions they raised. Today Science Speaks will look at a obstacle for researchers, while presentations pointed to directions for future studies First […]

FDA TB drug approval a milestone, with caveats

By on .

The U.S. Food and Drug Administration’s approval of the first new drug to treat tuberculosis in nearly half a century and the agency’s first use of its accelerated approval process to speed availability of TB medicine comes with cautions, and with a direction of work yet to be done, agency officials and treatment advocates agree. […]